Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
189.19B | 208.35B | 241.39B | 157.74B | 105.94B |
Gross Profit | ||||
30.24B | 64.06B | 55.10B | 22.86B | 10.18B |
EBIT | ||||
0.00 | 46.98B | 44.76B | 15.09B | -346.00M |
EBITDA | ||||
28.85B | 43.50B | 59.47B | 32.55B | 14.54B |
Net Income Common Stockholders | ||||
381.00M | 15.24B | -1.36B | 7.57B | -20.73B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
39.37B | 28.59B | 29.77B | 30.96B | 29.53B |
Total Assets | ||||
282.23B | 280.29B | 288.12B | 287.27B | 267.65B |
Total Debt | ||||
71.55B | 63.08B | 55.49B | 69.79B | 81.93B |
Net Debt | ||||
32.34B | 35.33B | 26.30B | 39.11B | 52.73B |
Total Liabilities | ||||
203.91B | 194.80B | 205.13B | 196.83B | 182.09B |
Stockholders Equity | ||||
59.25B | 70.28B | 67.55B | 75.46B | 71.25B |
Cash Flow | Free Cash Flow | |||
12.00B | 17.75B | 28.86B | 12.72B | -144.00M |
Operating Cash Flow | ||||
27.30B | 32.04B | 40.93B | 23.61B | 12.16B |
Investing Cash Flow | ||||
-13.25B | -14.87B | -13.71B | -5.69B | -7.86B |
Financing Cash Flow | ||||
-7.30B | -13.36B | -28.02B | -18.08B | 3.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | €102.09B | 7.68 | 13.29% | 6.17% | -10.73% | -23.13% | |
63 Neutral | £53.58B | 183.44 | 0.61% | 6.73% | -12.44% | -98.02% | |
61 Neutral | £192.09M | 4.19 | ― | -11.70% | ― | ||
56 Neutral | £2.72B | 21.62 | -2.87% | 12.93% | 29.33% | ― | |
55 Neutral | $7.05B | 3.40 | -6.09% | 6.09% | -0.43% | -51.04% | |
48 Neutral | £135.25M | 17.20 | -3.25% | ― | -28.38% | 90.60% |